The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 832.80
Bid: 835.00
Ask: 835.40
Change: -10.20 (-1.21%)
Spread: 0.40 (0.048%)
Open: 843.20
High: 844.60
Low: 832.00
Prev. Close: 843.00
INF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Informa adds F1000 Research to Taylor & Francis

10 Jan 2020 10:30

RNS Number : 3743Z
Informa PLC
10 January 2020
 

 

Informa LEI: 5493006VM2LKUPSEDU20 

Informa PLC Press Release

10 January 2020

Informa adds F1000 Research to the Taylor & Francis Open Access Portfolio

London: Informa (LSE: INF.L), the International Exhibitions, Events, Information Services and Advanced Learning Group, today announces further investment in developing its Open Access ("OA") publishing capabilities through the addition of F1000 Research Ltd. by Taylor & Francis.

Stephen A. Carter, Group Chief Executive, Informa PLC, said:

"Under the leadership of Annie Callanan in Taylor & Francis, we are deepening our Open Access and also now our Open Research capabilities."

He added:

"F1000 Research is a leader in its field, committed to the further development of independent, high quality Open Science and Research. We are delighted to welcome Rebecca Lawrence and the team from F1000 Research, and are committed to the further technology and capability development that Open Research needs."

Vitek Tracz, Founder, F1000, said:

"F1000 Research is a pioneer of quality and independence, with a deep commitment to Open Science and Research. Taylor & Francis is a great fit culturally and its commitment to further investment and development is timely, given the likely acceleration of Open services."

F1000 Research Ltd. offers fully managed, open research publishing services directly to research funders, learned societies and institutions, including the Wellcome Trust and the Bill & Melinda Gates Foundation.

Additionally, F1000Research is the leading independent open research publishing platform for scientists and academic scholars. Its innovative platform enables the rapid publication of academic research, whilst maintaining quality and transparency, and providing authors with greater autonomy through the process.

The addition of F1000 Research complements and extends Taylor & Francis's programme of investment to expand our presence and capabilities within the increasingly important OA publishing arena. It follows the addition of leading independent OA journal publisher, Dove Medical Press, in 2017 and ongoing internal investment in developing our range of OA publications and services, with more than 300 OA journals now published across our total journal portfolio of over 2,700 titles.

No financial details of the transaction were disclosed.

Enquiries

 

Informa PLC

Stephen A. Carter, Group Chief Executive

Gareth Wright, Group Finance Director

Richard Menzies-Gow, Director of IR & Comms

 

+44 (0)20 7017 5771

+44 (0)20 7017 7096

+44 (0)20 3377 3445

Teneo Strategy

Tim Burt / Zoë Watt

 

+44 (0)20 7240 2486

Notes to Editors

Informa PLC

Informa is a leading international Exhibitions, Events, Information Services and Scholarly Publishing Group with annual revenues approaching £3 billion. It helps commercial, professional and academic communities work smarter and make better decisions faster, through specialist content and intelligence, and opportunities to connect and learn. For more information, please visit www.informa.com.

About F1000 Research Ltd.

F1000 Research Ltd. provides innovative open access publishing platforms offering rapid publication and open peer review, whilst supporting data deposition and sharing for the research community.

F1000 Research Ltd.'s own publishing platform, F1000Research, was launched in 2013 and was the first open research publishing platform combining the ability to publish rapidly with functionality to ensure transparency, robustness and reproducibility of research. F1000Research's publishing model combines the benefits of 'pre-printing' (providing rapid publication) with quality and transparency (open data support and invited open peer review) and enables publication within days of submission, followed by open invited peer review.

Building upon the growth and success of its core platform, F1000 Research Ltd. also provides fully managed, open research publishing services directly to research funders and institutions, including Wellcome, the Bill & Melinda Gates Foundation and the Health Research Board Ireland, as well as to other scholarly publishers such as Emerald Publishing. F1000 Research combines opportunities offered by technology with a passion for identifying new ways to validate and share research.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQGPUMCGUPUUUU
Date   Source Headline
5th Aug 20216:19 pmRNSBlock listing Interim Review
5th Aug 20216:07 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNS2021 Half Year Results Statement
3rd Jun 20215:16 pmRNSResult of AGM
3rd Jun 20217:00 amRNSTrading Update
2nd Jun 20214:42 pmRNSDirector/PDMR Shareholding
24th May 20214:08 pmRNSDirector/PDMR Shareholding
30th Apr 202110:45 amRNSNotice of AGM
26th Apr 20217:00 amRNSMarket update on Financial Intelligence
22nd Apr 20217:00 amRNS2020 Full Year Results Statement
1st Apr 202110:15 amRNSTotal Voting Rights
22nd Mar 20213:35 pmRNSDirector/PDMR Shareholding
17th Mar 20219:35 amRNSExtension of Block Listing
3rd Mar 20213:15 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSBoard Update
19th Feb 20219:30 amRNSHolding(s) in Company
12th Feb 20211:15 pmRNSHolding(s) in Company
14th Jan 20217:00 amRNSDirector/PDMR Shareholding
6th Jan 20217:00 amRNSChair Succession
6th Jan 20217:00 amRNS2020 Year-End Update
23rd Dec 202011:24 amRNSGeneral Meeting Update
10th Dec 20201:53 pmRNSGeneral Meeting Date Extension
4th Dec 202010:15 amRNSBlock listing Interim Review
27th Nov 20205:31 pmRNSNotice of GM
11th Nov 20207:00 amRNSCOVID-19 Action Plan Update
29th Sep 20205:13 pmRNSIssue of Debt
25th Sep 20203:51 pmRNSHolding(s) in Company
21st Sep 20207:00 amRNSInforma Half-Year Results & COVID-19 Action Plan
31st Jul 20205:08 pmRNSTotal Voting Rights
3rd Jul 20202:01 pmRNSDirector/PDMR Shareholding
30th Jun 20205:57 pmRNSTotal Voting Rights
18th Jun 20203:03 pmRNSDirector/PDMR Shareholding
12th Jun 202011:25 amRNSResult of AGM
12th Jun 20207:00 amRNSAGM Trading Update
9th Jun 20202:33 pmRNSNotification of Change in AGM Venue
5th Jun 20202:50 pmRNSDirector/PDMR Shareholding
3rd Jun 20203:22 pmRNSBlock Listing Application
29th May 20205:12 pmRNSTotal Voting Rights
14th May 20205:15 pmRNSHolding(s) in Company
12th May 20206:15 pmRNSNotice of AGM
7th May 20204:55 pmRNSHolding(s) in Company
7th May 202012:49 pmRNSAnnual Financial Report
7th May 20209:12 amRNSDirector/PDMR Shareholding
6th May 20208:21 amRNSDirector/PDMR Shareholding
5th May 202010:32 amRNSAdditional Listing
4th May 20205:30 pmRNSInforma
4th May 20209:11 amRNSResult of Meeting
30th Apr 20205:46 pmRNSTotal Voting Rights
22nd Apr 20207:00 amRNSDirector/PDMR Shareholding
21st Apr 20204:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.